312537-44-3

Basic information

• Product Name: 6-bromo-3-tritylbenzo[d]oxazol-2(3H)-one
• Synonyms: 6-bromo-3-tritylbenzo[d]oxazol-2(3H)-one;3,5-dimethyl-pyrrole-2,4-dicarboxylic acid-2-ethyl ester-4-benzyl ester;6-Bromo-3-(triphenylmethyl)-2(3H)-benzoxazolone
• CAS NO: 312537-44-3
• Molecular Formula: C₂₆H₁₈BrNO₂
• Molecular Weight: 456.33062
• Mol File: 312537-44-3.mol
• Article Data: 5

Chemical Properties

• Boiling Point: 583.3±60.0 °C(Predicted)
• Appearance: /
• Density: 1.432±0.06 g/cm3(Predicted)
• PKA: -1.65±0.20(Predicted)
• CAS DataBase Reference: 6-bromo-3-tritylbenzo[d]oxazol-2(3H)-one(CAS DataBase Reference)
• NIST Chemistry Reference: 6-bromo-3-tritylbenzo[d]oxazol-2(3H)-one(312537-44-3)
• EPA Substance Registry System: 6-bromo-3-tritylbenzo[d]oxazol-2(3H)-one(312537-44-3)

Safety Data

• Hazardous Substances Data: 312537-44-3(Hazardous Substances Data)

Upstream product

• 19932-85-5 6-bromobenzo[d]oxazol-2(3H)-one 
• 76-83-5 trityl chloride 
• 38191-34-3 2-amino-5-bromophenol 

Downstream Products

• 906004-10-2 6-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-3-trityl-3H-benzooxazol-2-one 

Relevant articles and documents

ANTI-FIBROTIC PYRIDINONES

This application relates to polycyclic compounds with a pyridinone or pyridinone derivative core including, substituted pyridinones, 5,6- and 6,6- bicyclic heterocycles and substituted pyridine-thiones. This application also discloses methods of preparing these polycyclic compounds, pharmaceutical compositions and medicaments comprising said compounds and methods to treat, prevent or diagnose diseases, disorders or conditions associated with fibrosis.

COMBINATION OF A HYPNOTIC AGENT AND SUBSTITUTED BIS ARYL AND HETEROARYL COMPOUND AND THERAPEUTIC APPLICATION THEREOF

The invention concerns the combination of a short-acting hypnotic agent and a compound of formula (I): Wherein X, Y, Z, A, B, D, Ar, R1 and R2 are as defined herein. The combination of this invention is useful in treating a varie

Heterocyclic compounds useful as NMDA receptor selective subtype blockers

The invention relates to compounds of formula wherein Ar1 is pyridyl or phenyl, substituted by hydroxy, lower alkyl, halogen, amino, nitro, benzyloxy or lower alkoxy-lower alkoxy, or is the group wherein Z1 is a five membered heteroc